Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity?

Author： Bozlu M. Ulusoy E. Doruk E. Cayan S. Canpolat B. Schellhammer P.F. Akbay E.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.62, Iss.6, 2003-12, pp. : 1050-1053

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression

By Wammack R. Djavan B. Remzi M. Susani M. Marberger M.

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 1004-1007

Elsevier

Access to resources Recommend Favorite

Efficacy of one dose fluoroquinolone before prostate biopsy1

By Shandera K.C. Thibault G.P. Deshon G.E.

Urology, Vol. 52, Iss. 4, 1998-10 ,pp. : 641-643

Elsevier

Access to resources Recommend Favorite

Benign prostate tissue as prostate fossa biopsy finding in cases of biochemical failure after radical prostatectomy. Correlation to specimen margin status and possible treatment options

By Anagnostou T. Djavan B. Renzi M. Polyzois K. Alavi S. Doumas K. Lykourinas M.

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 23-23

Elsevier

Access to resources Recommend Favorite

Prostate biopsy and anaesthesia: An overview

By Aus Gunnar Damber Jan-Erik Hugosson Jonas

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 2, 2005-04 ,pp. : 124-129

Informa Healthcare

Access to resources Recommend Favorite

Biopsy protocol stability in a three-dimensional model of prostate cancer: changes in cancer yield after adjustment of biopsy positions

By Egevad L. Frimmel H. Mattson S. Bengtsson E. Busch C.

Urology, Vol. 54, Iss. 5, 1999-11 ,pp. : 862-868

Elsevier

Access to resources Recommend Favorite